Abstract B064: TRI-611, a selective, CNS-penetrant molecular glue degrader of ALK with anti-tumor activity against preclinical models of ALK-fusion positive non-small cell lung cancer including kinase inhibitor refractory tumors
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Andrew R. Conery, Artyom A. Alekseyenko, David Marcoux, Aaron G. Bart, Matt L. Harlow, Patrick R. Arsenault, Nico R. Cantone, Rebecca L. Casaubon, Hari B. Kamadurai, Aravind Prasad. Medikonda, Duncan E. Nunes, Vito J. Palombella, Kathleen I. Seyb, Tim J. Wigle, Maolin Yu, Aleksandra Zagulyaeva, Christine Zarate, Daniel S. La
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4415444230